Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Ulipristal acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ulipristal acetate and what is the scope of ulipristal acetate freedom to operate?

Ulipristal acetate
is the generic ingredient in two branded drugs marketed by Teva Pharms Usa and Lab Hra Pharma, and is included in two NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ulipristal acetate has forty-two patent family members in twenty-two countries.

There are four drug master file entries for ulipristal acetate. Two suppliers are listed for this compound.

Summary for Generic Name: ulipristal acetate

Tradenames:2
Patents:6
Applicants:2
NDAs:2
Drug Master File Entries: see list4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list31
Clinical Trials: see list443
Patent Applications: see list49
Drug Prices:see low prices
DailyMed Link:ulipristal acetate at DailyMed

Pharmacology for Ingredient: ulipristal acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes9,283,233► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes8,735,380► SubscribeY ► Subscribe
Teva Pharms Usa
LOGILIA
ulipristal acetate
TABLET;ORAL207952-001Feb 13, 2017ABRXNoNo► Subscribe► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes8,512,745► SubscribeY ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes8,962,603► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot